Public Health Interventions Cost Effectiveness Database (PHICED)

Introduction

The Public Health Interventions Cost Effectiveness Database (PHICED) is a database of bibliographic records related to public health areas. It includes cost-effectiveness studies, NICE guidance and decision tools relating to alcohol, obesity, physical activity and tobacco. It is aimed at professionals who provide or commission public health interventions.

The development of this tool was funded by Health England and forms part of the National Library for Public Health.

Further information

Find out about the methods used to produce PHICED.

Contact details

Please contact Sue Baughan if you have any feedback or comments about PHICED.

Sue Baughan

Assistant Director/Knowledge Transfer
tel: 01904 435262
email:

Search

Please note that the search filters operate automatically as they are chosen;-


	Public Health AreaThe public health areas currently included on the website are; alcohol, obesity, physical activity and tobacco.
	Limited By
	CountryThis allows the user to specify the country/region where the study was conducted
	Patient GroupThis allows the user to specify studies relating to a particular set of individuals with given characteristics.
	InterventionThis allows the user to specify whether the study evaluates primary prevention or secondary prevention.
		Searching Tips

Results

Now showing 5 per page. On this page 31 to 35

Showing all records

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41

Intervention	Reference	PH Area	Patient Group	Country
Secondary prevention	Shearer AT, Bagust A, Ampudia-Blasco FJ, Alvarez BM, Escolano EP, Paris G. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain. Pharmacoeconomics. 2006;24(Supplement 1):49-59.	Obesity	Adults, People with Diabetes	Europe (not UK)
Secondary prevention	Lacey LA, Wolf A, O'Shea D, Erny S, Ruof J. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland. International Journal of Obesity. 2005;29(8):975-82.	Obesity	Adults	Europe (not UK)
Primary Prevention	Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diabetes Care. 2007;30(1):128-34.	Obesity, Physical Activity	Adults, People with Diabetes	Europe (not UK)
Secondary prevention	Ara R, Brennan A. The cost-effectiveness of sibutramine in non-diabetic obese patients: evidence from four Western countries. Obesity Reviews. 2007;8(4):363-71.	Obesity	Adults	Europe (not UK), UK
Secondary prevention	Plans-Rubio P. Cost-effectiveness of cardiovascular prevention programs in Spain. International Journal of Technology Assessment in Health Care. 1998;14(2):320-30.	Tobacco	Adults, People with CHD	Europe (not UK)
Show per page

Updated September 2011, based on searches undertaken on 24th August 2011